Literature DB >> 15569750

Predictors of clinical outcome in patients receiving local intra-arterial thrombolysis without subsequent symptomatic intracranial hemorrhage against acute middle cerebral artery occlusion.

Tatsuro Takada1, Masahiro Yasaka, Kazuo Minematsu, Hiroaki Naritomi, Takenori Yamaguchi.   

Abstract

BACKGROUND AND
PURPOSE: The factors that predict favorable outcome after local intra-arterial thrombolysis (LIT) remain unknown. We aimed to clarify these factors in patients with middle cerebral artery occlusion treated by LIT.
METHODS: We performed LIT in 26 consecutive patients who had middle cerebral artery occlusion with a modified Rankin scale (mRS) score <or=2 before stroke onset. We assessed background characteristics, angiographic findings, and mRS score at discharge. We compared these factors between patients with good outcome (mRS score, <or=2) and those with poor outcome (mRS score, >or=3).
RESULTS: The duration from symptom onset to hospital admission was 0.96 +/- 0.87 (mean +/- SD) hour and from onset of stroke to LIT was 3.78 +/- 1.17 hours. No patients developed symptomatic intracerebral hemorrhage or died. Thirteen patients achieved good outcomes. No significant differences existed between the two groups in baseline National Institutes of Health Stroke Scale (NIHSS) scores, time from stroke onset to LIT, blood pressure, early CT signs, or subsequent hemorrhagic transformation shown by CT. However, univariate analysis showed that patients with good outcomes were younger, more often had absence of hypertension history, had better collaterals shown by angiography, and had better recanalization rates than those with poor outcomes. NIHSS scores after LIT were lower in patients with good outcomes than in patients with poor outcomes. Logistic regression analysis indicated improvement of the NIHSS scores by >or=2 immediately after LIT was independently associated with good outcome.
CONCLUSION: Improvement of the NIHSS score by >or=2 immediately after LIT is a useful predictor of patient outcome at discharge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569750      PMCID: PMC8148709     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

Authors:  E Mori; Y Yoneda; M Tabuchi; T Yoshida; S Ohkawa; Y Ohsumi; K Kitano; A Tsutsumi; A Yamadori
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

3.  Local intra-arterial thrombolysis in acute ischemic stroke.

Authors:  F Gönner; L Remonda; H Mattle; M Sturzenegger; C Ozdoba; K O Lövblad; R Baumgartner; C Bassetti; G Schroth
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

4.  Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome.

Authors:  T Moulin; F Cattin; T Crépin-Leblond; L Tatu; D Chavot; M Piotin; J F Viel; L Rumbach; J F Bonneville
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

5.  Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis.

Authors:  Chelsea S Kidwell; Jeffrey L Saver; Joaquin Carneado; James Sayre; Sidney Starkman; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Fernando Vinuela
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.

Authors:  D E Levy; T G Brott; E C Haley; J R Marler; G L Sheppard; W Barsan; J P Broderick
Journal:  Stroke       Date:  1994-02       Impact factor: 7.914

8.  Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Authors:  H P Adams; T G Brott; A J Furlan; C R Gomez; J Grotta; C M Helgason; T Kwiatkowski; P D Lyden; J R Marler; J Torner; W Feinberg; M Mayberg; W Thies
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

9.  Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.

Authors:  Jaroslaw Aronowski; Roger Strong; Ali Shirzadi; James C Grotta
Journal:  Stroke       Date:  2003-04-10       Impact factor: 7.914

10.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  4 in total

1.  Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome.

Authors:  M Arnold; K Nedeltchev; L Remonda; U Fischer; C Brekenfeld; B Keserue; G Schroth; H P Mattle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

Review 2.  Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review.

Authors:  Albert J Yoo; Benjamin Pulli; R Gilberto Gonzalez
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-07

3.  Stability of ischemic core volume during the initial hours of acute large vessel ischemic stroke in a subgroup of mechanically revascularized patients.

Authors:  Stephanos Finitsis; Andrea Kemmling; Stephanie Havemeister; Götz Thomalla; Jens Fiehler; Caspar Brekenfeld
Journal:  Neuroradiology       Date:  2014-01-28       Impact factor: 2.804

4.  Predictors of functional outcome vary by the hemisphere of involvement in major ischemic stroke treated with intra-arterial therapy: a retrospective cohort study.

Authors:  Albert J Yoo; Javier Romero; Reza Hakimelahi; Raul G Nogueira; James D Rabinov; Johnny C Pryor; R Gilberto González; Joshua A Hirsch; Pamela W Schaefer
Journal:  BMC Neurol       Date:  2010-04-23       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.